greeksoup/ stock research
Stock research / United States / Funds / Empery Asset Management, LP

Empery Asset Management, LP

CIK 1469336 · latest 13F filed 11 August 2026 · Read the filing on EDGAR

Empery Asset Management, LP reported 32 US-listed holdings worth $86.5 million in its 13F for the quarter ended 30 June 2026, filed 11 August 2026. Its largest: X4 Pharmaceuticals Inc. (37.4%), Volcon Inc. (12.1%) and Nervgen Pharma Corp. (9.5%). Against the quarter before, it opened 12 positions, added to 0, trimmed 7 and sold out of 12.

Reported holdings$86.5M+4.2% on Q1 2026
Positions32as many as Q1 2026
The largest ten90.7%of its reported holdings
Latest 13FQ2 2026filed 11 August 2026
Where the money is
OpenedHeldTrimmed
XFOR37.4%EMPD12.1%NGEN9.5%DTIL7.1%CLNN6.5%ANVS5.2%LTRN4.1%AMC3.8%TNYA3.3%YDDL1.8%CYN1.5%VENU1.3%GLNDW1.0%URG1.0%18 more4.5%

The 14 largest of its 32 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.

Reported holdings, quarter by quarter
Q4 2025: $113.4 million in 31 positions$113MQ4 25Q1 2026: $83.0 million in 32 positions$83.0MQ1 26Q2 2026: $86.5 million in 32 positions$86.5MQ2 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What its reported holdings returned

Held through each quarter, the holdings it reported returned +9.2% over the 2 quarters to 30 June 2026, against +9.5% for the S&P 500.

Its reported holdingsThe S&P 500
95100105110Q4 25Q1 26Q2 26Its holdings +9.2%S&P 500 +9.5%

Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.

What it did on the quarter

Opened 12Held 13Trimmed 7Sold out 12
Opened: 12Held: 13Trimmed: 7Sold out: 12

Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held

Opened 12

  1. Nervgen Pharma Corp. NGEN$8.2 million
  2. Clene Inc. CLNN$5.6 million
  3. Annovis Bio Inc ANVS$4.5 million
  4. Lantern Pharma LTRN$3.5 million
  5. Amc Entmt Hldgs Inc. AMC$3.3 million
  6. One and One Green Technologi YDDL$1.5 million
  7. Greenland Energy Co W Exp 04/21/203 GLNDW$850,000
  8. Cellectar Biosciences Inc. CLRB$527,102

and 4 more in the table below

Trimmed 7

  1. X4 Pharmaceuticals Inc. XFOR-2.0 million shares · -23%
  2. Precision Biosciences Inc. DTIL-1.2 million shares · -61%
  3. Venu Hldg Corp. VENU-494,911 shares · -49%
  4. Satellos Bioscience Inc. MSLE-123,000 shares · -53%
  5. Tenaya Therapeutics Inc. TNYA-423,818 shares · -10%
  6. Parazero Technologies Ltd PRZO-168,428 shares · -60%
  7. Cyngn Inc. CYN-30,725 shares · -3%

Sold out of 12

  1. Imperial Pete Inc. IMPP$3.8 million last quarter
  2. U S Energy Corp. Del BSIN$1.7 million last quarter
  3. Scynexis Inc. SCYX$1.7 million last quarter
  4. Critical Metals Corp. CRML$1.0 million last quarter
  5. Promis Neurosciences Inc. PMN$766,483 last quarter
  6. Super League Enterprise Inc. Com New SLE$491,793 last quarter
  7. Talphera Inc. TLPH$441,030 last quarter
  8. Benitec Biopharma Inc. BNTC$324,186 last quarter

What it holds

CompanySharesValueOf its bookChange in shares
X4 Pharmaceuticals Inc. XFOR6.9M$32.4 million37.43%-2.0M
Volcon Inc. EMPD2.9M$10.4 million12.06%no change
Nervgen Pharma Corp. NGEN4.0M$8.2 million9.53%new
Precision Biosciences Inc. DTIL776.1K$6.1 million7.05%-1.2M
Clene Inc. CLNN916.5K$5.6 million6.52%new
Annovis Bio Inc ANVS2.4M$4.5 million5.17%new
Lantern Pharma LTRN842.7K$3.5 million4.06%new
Amc Entmt Hldgs Inc. AMC1.7M$3.3 million3.77%new
Tenaya Therapeutics Inc. TNYA3.9M$2.9 million3.30%-423.8K
One and One Green Technologi YDDL761.7K$1.5 million1.78%new
Cyngn Inc. CYN927.1K$1.3 million1.49%-30.7K
Venu Hldg Corp. VENU512.8K$1.2 million1.35%-494.9K
Greenland Energy Co W Exp 04/21/203 GLNDW1.0M$850,0000.98%new
Ur-Energy Inc. URG620.1K$843,3850.98%no change
Satellos Bioscience Inc. MSLE107.1K$832,7030.96%-123.0K
Jaguar Uranium Corp. JAGU487.5K$814,1250.94%no change
Cellectar Biosciences Inc. CLRB189.6K$527,1020.61%new
Scynexis Inc. SCYX126.5K$514,6560.60%new
Aileron Therapeutics Inc. RNTX370.8K$385,6670.45%new
BTC Digital Ltd BTCT350.9K$288,9120.33%new
Briacell Therapeutics Corp. BCTXL300.0K$267,0000.31%no change
Maris Tech Ltd MTEKW297.6K$58,0320.07%no change
Parazero Technologies Ltd PRZO113.8K$55,3380.06%-168.4K
Duke Robotics Corp. DUKRW35.0K$45,1500.05%new
Nutriband Inc. NTRBW40.2K$40,2180.05%no change
Renatus Tactical Acquis RTACW50.0K$38,0000.04%no change
Spectral Ai Inc. MDAIW33.3K$18,5010.02%no change
Jeffs Brands Ltd NEXRW360.6K$10,4210.01%no change
Cea Industries Inc. BNCWW500.0K$9,2500.01%no change
FGI Industries Ltd FGIWW83.9K$7,9730.01%no change
Neurosense Therapeutics Ltd NRSNW100.4K$6,3250.01%no change
Nexgel Inc. NXGLW90.0K$3,4740.00%no change
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before; the 12 it sold out of are in the box above.